Through microarray analysis to identify gene signatures of potential diagnostic value, a substantial downregulation of chemerin expression in adrenocortical carcinoma versus benign adrenal adenomas was discovered in two independent cohorts [98,99]. This evidence concerns the gene RARRES2 and adrenal cortex adenoma.